Latest Articles

Article Type

You have access
Exosomal miR-145 and miR-885 Regulate Thrombosis in COVID-19
Jessica Gambardella, Urna Kansakar, Celestino Sardu, Vincenzo Messina, Stanislovas S. Jankauskas, Raffaele Marfella, Paolo Maggi, Xujun Wang, Pasquale Mone, Giuseppe Paolisso, Daniela Sorriento and Gaetano Santulli

Journal of Pharmacology and Experimental Therapeutics January 2023, 384 (1) 109-115; DOI: https://doi.org/10.1124/jpet.122.001209
Open Access
Identification and Characterization of ACP-5862, the Major Circulating Active Metabolite of Acalabrutinib: Both Are Potent and Selective Covalent Bruton Tyrosine Kinase Inhibitors
Terry Podoll, Paul G. Pearson, Allard Kaptein, Jerry Evarts, Gerjan de Bruin, Maaike Emmelot-van Hoek, Anouk de Jong, Bart van Lith, Hao Sun, Stephen Byard, Adrian Fretland, Niels Hoogenboom, Tjeerd Barf and J. Greg Slatter

Journal of Pharmacology and Experimental Therapeutics January 2023, 384 (1) 173-186; DOI: https://doi.org/10.1124/jpet.122.001116
Open Access
The Role of microRNA in the Development, Diagnosis, and Treatment of Cardiovascular Disease: Recent Developments
Anetta Wronska

Journal of Pharmacology and Experimental Therapeutics January 2023, 384 (1) 123-132; DOI: https://doi.org/10.1124/jpet.121.001152
You have access
Effects of 2,5-Dimethoxy-4-Methylamphetamine (DOM) and 2-Piperazin-1-yl-Quinoline (Quipazine) on Fentanyl Versus Food Choice in Rhesus Monkeys
David R. Maguire

Journal of Pharmacology and Experimental Therapeutics January 2023, 384 (1) 155-162; DOI: https://doi.org/10.1124/jpet.122.001318
You have access
Regulation of Ferroptosis by Non-Coding RNAs: Mechanistic Insights
Ammad Ahmad Farooqi, Gulnara Kapanova, Sundetgali Kalmakhanov, Abay Z. Kussainov and Zaure Datkhayeva

Journal of Pharmacology and Experimental Therapeutics January 2023, 384 (1) 20-27; DOI: https://doi.org/10.1124/jpet.121.001225
Open Access
RNAi-Based Therapeutics and Novel RNA Bioengineering Technologies
Gavin M. Traber and Ai-Ming Yu

Journal of Pharmacology and Experimental Therapeutics January 2023, 384 (1) 133-154; DOI: https://doi.org/10.1124/jpet.122.001234
You have access
The Novel, Clinical Stage Soluble Guanylate Cyclase Activator BI 685509 Protects from Disease Progression in Models of Renal Injury and Disease
Glenn A. Reinhart, Paul C. Harrison, Kathleen Lincoln, Hongxing Chen, Peng Sun, Jon Hill, Hu Sheng Qian, Mark McHugh, Holly Clifford, Khing Jow Ng, Hong Wang, Danielle Fowler, Kristina K. Gueneva-Boucheva, Todd Bosanac, Diane Wong, Ryan M. Fryer, Chris Sarko, Carine M Boustany-Kari and Steven S. Pullen

Journal of Pharmacology and Experimental Therapeutics December 6, 2022, JPET-AR-2022-001423; DOI: https://doi.org/10.1124/jpet.122.001423
You have access
Neutralizing MIP3a reduces renal immune cell infiltration and progressive renal injury in young obese Dahl salt-sensitive rats
Ubong S Ekperikpe, Bibek Poudel, Corbin A Shields, Sautan Mandal, Denise C Cornelius and Jan M Williams

Journal of Pharmacology and Experimental Therapeutics December 5, 2022, JPET-AR-2022-001298; DOI: https://doi.org/10.1124/jpet.122.001298
You have access
Protein 14-3-3 Influences the Response of the Cardiac Sodium Channel Na_v1.5 to Anti-Arrhythmic Drugs
Yang Zheng and Isabelle Deschenes

Journal of Pharmacology and Experimental Therapeutics December 2, 2022, JPET-AR-2022-001407; DOI: https://doi.org/10.1124/jpet.122.001407
You have access
Delta opioid receptor-mediated antidepressant-like effects of diprenorphine in mice
Keith M Olson, Todd M. Hillhouse, Gwendolyn E Burgess, Joshua L. West, James E Hallahan, Isaac J Dripps, Allison G Ladetto, Kenner C. Rice, Emily M. Jutkiewicz and John R. Traynor

Journal of Pharmacology and Experimental Therapeutics December 1, 2022, JPET-AR-2022-001182; DOI: https://doi.org/10.1124/jpet.122.001182

Main menu

User menu

Search

Latest Articles

Pages

Navigate

More Information

ASPET's Other Journals